NASDAQ:ABIO

ARCA biopharma (ABIO) Stock Forecast, Price & News

$2.01

0.00 (0.00%)

(As of 10/2/2023 ET)

Compare

Today's Range: $2.00
▼
$2.04
50-Day Range: $2.00
▼
$2.07
52-Week Range: $1.85
▼
$2.70

Volume: 36,431 shs
Average Volume: 26,261 shs
Market Capitalization: $28.96 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About ARCA biopharma (NASDAQ:ABIO) Stock

ARCA biopharma, Inc., a clinical development stage biopharmaceutical company, engages in the development and commercialization of genetically targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with chronic heart failure. It is also developing Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. ARCA biopharma, Inc. has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. The company was founded in 2004 and is headquartered in Westminster, Colorado.

ABIO Price History

30 days | 90 days | 365 days | Advanced Chart

ABIO Stock News Headlines

October 2, 2023 | americanbankingnews.com

ARCA biopharma, Inc. (NASDAQ:ABIO) Short Interest Up 9.5% in September

September 27, 2023 | msn.com

ARCA legend Kimmel keeps the racing itch scratched as a truck chief with TRICON

October 2, 2023 | Behind the Markets (Ad)

How A.I. Could Make Most 21st Century Diseases EXTINCT

On December 22, 2022, AI discovered a new treatment for multiple myeloma... in just 4 months... On March 19, 2023, AI discovered a new drug for liver cancer... in only 30 days... There's one small-cap at the center of it all. Bill Gates owns 7 million shares... Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares...

September 25, 2023 | americanbankingnews.com

ARCA biopharma (NASDAQ:ABIO) Receives New Coverage from Analysts at StockNews.com

September 21, 2023 | msn.com

ARCA Wunderkind: NASCAR Fans Should 'Love' Who's Coming Down the Road

September 10, 2023 | uk.finance.yahoo.com

ABIO - ARCA biopharma, Inc.

September 8, 2023 | msn.com

Rookie Connor Mosack wins first career ARCA race at Kansas Speedway

September 6, 2023 | msn.com

Five drivers to watch in Friday’s ARCA Sioux Chief Fast Track 150 at Kansas Speedway

October 2, 2023 | Behind the Markets (Ad)

How A.I. Could Make Most 21st Century Diseases EXTINCT

August 22, 2023 | msn.com

Racing for Stride ARCA driver honors disabled veterans

August 18, 2023 | msn.com

Watkins Glen Day 1 Recap: ARCA race comes down to final turn; tough day for Frankie Muniz

August 18, 2023 | msn.com

Love bumps Zilisch on last lap to win ARCA race at Watkins Glen

August 18, 2023 | msn.com

Frankie Muniz sees Watkins Glen as chance to earn first career ARCA victory

August 14, 2023 | msn.com

Corey LaJoie enters ARCA Menards Series race for Watkins Glen weekend

August 13, 2023 | msn.com

ARCA drivers Christian Rose, Conner Jones get into heated scuffle after spin out

August 11, 2023 | yahoo.com

Actor Turned Racer Frankie Muniz Is No Joke in ARCA Racing Series

July 30, 2023 | finanznachrichten.de

ARCA biopharma, Inc.: ARCA biopharma Announces Second Quarter 2023 Financial Results

July 27, 2023 | sports.yahoo.com

Sekisui Voltek Announces Sponsorship of Coldwater's Rodgers for ARCA race

July 21, 2023 | sports.yahoo.com

POCONOTES: Actor Muniz in middle of ARCA points battle

July 21, 2023 | finance.yahoo.com

ARCA biopharma Announces Second Quarter 2023 Financial Results

July 15, 2023 | msn.com

Fenhaus wins Calypso 150 in ARCA Menards Series

July 15, 2023 | sports.yahoo.com

'The end goal is the Cup Series': Frankie Muniz seeking more in NASCAR than hot ARCA start

July 13, 2023 | finance.yahoo.com

We're Not Very Worried About ARCA biopharma's (NASDAQ:ABIO) Cash Burn Rate

July 11, 2023 | msn.com

ARCA driver Sean Hingorani suspended for wrecking teammate

July 10, 2023 | yahoo.com

ARCA-Level NASCAR Driver Suspended for Wrecking Teammate

June 25, 2023 | msn.com

Frankie Muniz crashes hard in ARCA race, picks up first DNF

June 15, 2023 | msn.com

Frankie Muniz, Jesse Love and Christian Rose highlight who to watch for in the Berlin ARCA 200 this Saturday

See More Headlines

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Company Calendar

Last Earnings: 7/21/2023
Today: 10/02/2023
Next Earnings (Estimated): 10/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostic substances
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ABIO
CUSIP: N/A
CIK: 907654
Web: arcabio.com
Phone: (720) 940-2100
Fax: 720-208-9261
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.43)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,930,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -15.43%
Return on Assets: -14.80%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 25.44
Quick Ratio: 25.44

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.89 per share
Price / Book: 0.70

Miscellaneous

Outstanding Shares: 14,410,000
Free Float: N/A
Market Cap: $29.11 million
Optionable: Not Optionable
Beta: 1.30

10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

Dr. Michael R. Bristow M.D. (Age 78)
Ph.D., Co-Founder, Pres, CEO & Director
Comp: $358.8k

Mr. Thomas A. Keuer (Age 64)
Chief Operating Officer
Comp: $360.59k

Mr. C. Jeffrey Dekker CPA (Age 58)
Chief Financial Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

ABIO Stock - Frequently Asked Questions

How have ABIO shares performed in 2023?: ARCA biopharma's stock was trading at $2.37 at the beginning of 2023. Since then, ABIO stock has decreased by 14.8% and is now trading at $2.02.
View the best growth stocks for 2023 here.
Are investors shorting ARCA biopharma?: ARCA biopharma saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 265,000 shares, an increase of 9.5% from the August 31st total of 242,000 shares. Based on an average daily volume of 20,600 shares, the days-to-cover ratio is currently 12.9 days. Approximately 1.9% of the company's stock are sold short.
View ARCA biopharma's Short Interest.
When is ARCA biopharma's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, October 27th 2023.
View our ABIO earnings forecast.
How were ARCA biopharma's earnings last quarter?: ARCA biopharma, Inc. (NASDAQ:ABIO) posted its earnings results on Friday, July, 21st. The biopharmaceutical company reported ($0.10) earnings per share (EPS) for the quarter.
What is Michael R. Bristow's approval rating as ARCA biopharma's CEO?: 1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ARCA biopharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).
What is ARCA biopharma's stock symbol?: ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO."
How do I buy shares of ARCA biopharma?: Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is ARCA biopharma's stock price today?: One share of ABIO stock can currently be purchased for approximately $2.02.
How much money does ARCA biopharma make?: ARCA biopharma (NASDAQ:ABIO) has a market capitalization of $29.11 million. The biopharmaceutical company earns $-9,930,000.00 in net income (profit) each year or ($0.43) on an earnings per share basis.
How can I contact ARCA biopharma?: ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The official website for the company is arcabio.com. The biopharmaceutical company can be reached via phone at (720) 940-2100, via email at derek.cole@arcabio.com, or via fax at 720-208-9261.

This page (NASDAQ:ABIO) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ARCA biopharma (ABIO) Stock Forecast, Price & News

About ARCA biopharma (NASDAQ:ABIO) Stock

ABIO Price History

ABIO Stock News Headlines

ABIO Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

ABIO Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info